Related Experiment Videos
Plasminogen activator activity levels in patients with Behçet's syndrome
Archives of Ophthalmology (Chicago, Ill. : 1960)
|July 1, 1985
Summary
Patients with Behcet's syndrome show decreased plasminogen activator activity. This reduction in fibrinolytic function may correlate with disease severity, impacting blood clot breakdown.
Area of Science:
- Biochemistry
- Hematology
- Immunology
Background:
- Behcet's syndrome is a complex inflammatory disorder with unclear etiology.
- Impaired fibrinolysis, the breakdown of blood clots, is implicated in thrombotic events.
Purpose of the Study:
- To investigate plasminogen activator activity in patients with Behcet's syndrome.
- To explore the potential association between fibrinolytic function and disease severity.
Main Methods:
- Analysis of plasma samples from 37 Behcet's syndrome patients.
- Measurement of plasminogen activator activity using euglobulin lysis time, amidolytic activity (Testzym method), and fibrin plate assays.
Main Results:
- A significant decrease in plasminogen activator activity was observed across all tested methods.
- Reduced fibrinolytic capacity was a consistent finding in the patient cohort.
Conclusions:
- Patients with Behcet's syndrome exhibit diminished plasminogen activator activity.
- This hypofibrinolytic state may contribute to the thrombotic complications seen in Behcet's syndrome and could be linked to disease severity.